electroCore, Inc. (ECOR) vs ImmuCell Corporation (ICCC)
A side-by-side comparison of electroCore, Inc. and ImmuCell Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ECOR
electroCore, Inc.
$10.22HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
ICCC
ImmuCell Corporation
$9.75HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ECOR vs ICCC
growth of $100 · dividends reinvested · last 8yECOR -96.6% (-34.5%/yr)ICCC +44.4% (+4.7%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
ECOR ICCC
ECOR vs ICCC: by the numbers
- •ECOR is the larger company ($92M vs $88M market cap).
- •ICCC is profitable (2.57% net margin) while ECOR runs a net loss (-39.96%).
- •ECOR grew revenue faster over the past five years (52.51% vs 13.74% CAGR).
Metrics side by side
Valuation
| Metric | ECOR | ICCC |
|---|---|---|
| P/E ratio | N/A | 115.25 |
| P/S ratio | 2.49 | 2.88 |
| P/B ratio | N/A | 2.81 |
| EV / EBITDA | N/A | 14.69 |
| FCF yield | N/A | 4.78% |
Profitability
| Metric | ECOR | ICCC |
|---|---|---|
| Gross margin | 87.06% | 40.32% |
| Operating margin | -37.64% | 12.60% |
| Net margin | -39.96% | 2.57% |
| ROE | N/A | 2.51% |
| ROIC | -217.73% | 8.16% |
Growth (annualized)
| Metric | ECOR | ICCC |
|---|---|---|
| Revenue CAGR (5Y) | 52.51% | 13.74% |
| Total return CAGR (5Y) | -8.10% | 0.65% |
Frequently asked
- Which has grown faster, ECOR or ICCC?
- Over the past five years, ECOR grew revenue faster — ECOR at a 52.51% CAGR versus ICCC at 13.74%.
- Is ECOR or ICCC more profitable?
- ICCC runs the higher net margin — ECOR at -39.96% versus ICCC at 2.57%.
- How have ECOR and ICCC total returns compared?
- Over the past 5 years, ECOR delivered -8.10% and ICCC delivered 0.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioelectroCore ROEImmuCell ROEelectroCore operating marginImmuCell operating marginelectroCore revenue growthImmuCell revenue growthelectroCore free cash flowImmuCell free cash flow
electroCore & ImmuCell appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.